Advancements in Photonic Biosensor Technologies and Machine Learning Algorithms for Continuous Glucose Monitoring in Diabetes Management
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This Continuous glucose management (CGM) is changing due to advances in ML algorithms as well as in photonic biosensor technologies. Various biofluids, such as blood, sweat, saliva, tears, and interstitial fluid, are sensed through noninvasive and accurate photonic biosensors using light methods. CMG devices are paired with machine learning algorithms that provide real-time information, predictive insights, and personalized glycaemic control. The integration of these technologies overcomes the problems of invasive, biofouled, expensive, and time-lag-burdening conventional CGMs. Recently, sensors augmented with nanomaterials have become more accurate and biocompatible. Glycaemic prediction generated early to aid dynamic insulin adjustments to prevent glycaemic excursions is based on ML-driven prediction models. Data-sharable, remote healthcare monitoring capabilities are also offered by wearable biosensors in conjunction with Internet of Things (IoT) devices. But, as with any emerging technology, there remain obstacles to biofouling mitigation, long-term sensor stability, and cost reduction. This study demonstrates the revolutionary potential of photonic biosensing and machine learning for optimal glycaemic control and improved patient outcomes.
Fields of Study & Subjects
Spectroscopy Techniques in Biomedical and Chemical Research
Diabetes Management and Research
Non-Invasive Vital Sign Monitoring
Publication details
- Journal / source
- CRC Press eBooks
- Pages
- 368–373
- Publication date
- 31 March 2026
- Language
- EN
- Document type
- Book chapter